The Latest SROM Research: What You Need To Know - OpenSIPS Trunking Solutions

However, current research suggests that srom is comparable to methadone in retaining patients in treatment and reducing heroin use;

Other studies have reported greater treatment satisfaction, reduced cravings, fewer side eects, and reduced dysthymia.

To assess the efficacy of slow release oral morphine (srom) as a treatment for opioid use disorder (oud).

Three electronic databases were searched : Read also: Unidentified Ginger Leak: Prepare For A Mind-Blowing Revelation

The ability to offer srom (in addition to buprenorphine or methadone) increased rates of oat initiation among hospitalised patients.

Increasing access to srom would help narrow the opioid use disorder treatment gap of unmet need.

Experimental studies show that benefits of srom over methadone include less heroin craving, better tolerability, and higher patient satisfaction and mental stability.